Business
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research and development investment, underscoring the strategic importance of Canada in the growth of Daiichi Sankyo as a global leader in oncology.
About this update from Daiichi Sankyo Company, Limited
[{"type":"list","items":[{"val":[{"type":"text","content":"Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines","length":123,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":123,"olType":false},{"type":"text","content":"TORONTO, Jan. 21, 2026 /PRNewswire/ -- Daiichi Sankyo (TSE: 4568) has further established its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and research and development investment, underscoring the strategic importance of Canada in the growth of Daiichi Sankyo as a global leader in oncology.","length":366,"tagName":"p"},{"type":"image","alt":"Daiichi Sankyo executives and guests participate in a traditional Kagami Biraki (sake barrel breaking) ceremony, symbolizing new beginnings, harmony and prosperity. (From left to right: Fatih Yedikardes, Magnus Gisel, Sunao Manabe, Miho Matsui, Hiroyuki Okuzawa, Tyler Allsopp).","displaySize":"","headline":null,"caption":"Daiichi Sankyo executives and guests participate in a traditional Kagami Biraki (sake barrel breaking) ceremony, symbolizing new beginnings, harmony and prosperity. (From left to right: Fatih Yedikardes, Magnus Gisel, Sunao Manabe, Miho Matsui, Hiroyuki Okuzawa, Tyler Allsopp).","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":306,"url":"https://media.zenfs.com/en/prnewswire.com/4895d62f5f93b305c59d528f88db3d99"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JR7HPGRXwt1.AfIHsKNPgg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUzOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4895d62f5f93b305c59d528f88db3d99","width":400,"height":306}}},{"type":"text","content":""Establishing a permanent headquarters in Toronto represents a significant milestone in our global expansion and reflects the strong commitment of Daiichi Sankyo to patients and partners in Canada," said Masahiro Kato, Managing Director, Europe and Canada, Daiichi Sankyo. "Canada is home to a vibrant healthcare and life sciences ecosystem where we see immense potential for continued growth through scientific innovation and collaboration, solidifying Canada's role as a global contributor to improve standards of care."","length":546,"tagName":"p"},{"type":"text","content":""Our government is protecting Onta...